User profiles for KONSTANTINOS PAPAZISIS

Konstantinos Papazisis

Euromedica General Clinic Thessaloniki
Verified email at oncomedicare.com
Cited by 3672

[HTML][HTML] Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells

MJ Grimshaw, L Cooper, K Papazisis… - Breast Cancer …, 2008 - Springer
Introduction The identification of potential breast cancer stem cells is of importance as the
characteristics of stem cells suggest that they are resistant to conventional forms of therapy. …

[HTML][HTML] Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations

…, A Koumarianou, C Markopoulos, K Papazisis… - BMC cancer, 2019 - Springer
Background Hereditary cancer predisposition syndromes are responsible for approximately
5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk …

Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T …

HR Bohnenkamp, KT Papazisis, JM Burchell… - Cellular …, 2007 - Elsevier
Toll-like receptors (TLRs) recognise specific molecular signatures of pathogens and trigger
antimicrobial defence responses. Thereby, two independent signalling pathways can be …

The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece

…, M Gueorguiev, S Chrisafi, KT Papazisis… - Cancer letters, 2005 - Elsevier
The aim of this study was to explore a possible association between p53 codon 72, Her 2
codon 655 and MTHFR C677T polymorphisms and breast cancer in Northern Greece. We …

Axillary lymph node tattooing and targeted axillary dissection in breast cancer patients who presented as cN+ before neoadjuvant chemotherapy and became cN0 …

…, T Zarampoukas, V Zacharopoulou, K Papazisis - Clinical breast …, 2019 - Elsevier
Introduction Targeted axillary dissection (TAD) is an alternative to axillary dissection for
breast cancer patients who presented as cN+ before neoadjuvant chemotherapy (NAC) and …

Treatment with adjuvant abemaciclib plus endocrine therapy in patients with high-risk early breast cancer who received neoadjuvant chemotherapy: a prespecified …

…, D Grecea, JA Garcia-Saenz, K Papazisis… - JAMA …, 2022 - jamanetwork.com
Importance Patients selected to receive neoadjuvant chemotherapy (NAC) are usually those
at higher risk of relapse, and there is a need to find better therapeutic options for these …

[HTML][HTML] Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

LF Kontovinis, KT Papazisis, P Touplikioti, C Andreadis… - BMC cancer, 2009 - Springer
Background Sunitinib is a protein tyrosine kinase-inhibitor targeting VEGFR, c-kit and
PDGFR. It has been approved for the treatment of metastatic renal-cell carcinoma and …

Antiproliferative effect of mineral trioxide aggregate, zinc oxide-eugenol cement, and glass-ionomer cement against three fibroblastic cell lines

EA Koulaouzidou, KT Papazisis, NA Economides… - Journal of …, 2005 - Elsevier
An important requirement for dental materials placed in direct contact with living tissues is
biocompatibility. The purpose of this study was to evaluate the antiproliferative activity of three …

In vitro evaluation of the cytotoxicity of ProRoot MTA and MTA Angelus

…, P Beltes, G Geromichalos, K Papazisis - Journal of oral …, 2008 - jstage.jst.go.jp
The purpose of the present in vitro study was to compare the cytotoxic effect of two commercially
available brands of mineral trioxide cement (ProRoot MTA and MTA Angelus), modified …

[HTML][HTML] Prognostic significance of low HER2 expression in patients with early hormone receptor positive breast cancer

…, I Natsiopoulos, K Papazisis - Cancer diagnosis & …, 2022 - ncbi.nlm.nih.gov
Background/Aim: A possible role of antibody-drug conjugates against tumors with low HER2-expression,
leads to the emergence of a new “low-HER2” classification in breast cancer, …